Table 6.
Representation of Characterization Rubrics in Stem Cell Databases (Plus Sign Indicates Presence in a Database)
MIACARM Module | Rubric | SyStemCell | CODEX | ESTOOLS | SCDE | StemFormatics | LINCS | LifeMap Discovery | StemMapper | ESCAPE | SKiP | hPSCreg | CellNet | StemCellNet | HSC-explorer | CORTECON | ESCD |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Project | 1. Summary | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
2. Organization | + | + | + | + | + | + | + | + | + | + | + | + | |||||
3. PI/Corresponding researcher | + | + | + | + | + | + | |||||||||||
4. Publication | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |||
2. Assay | 5. Clinical Trials for Cell Therapies | + | |||||||||||||||
3. Source Cell | 6. Stem Cell Type/Name | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
7. Stem Cell Subtype | + | + | + | + | |||||||||||||
8. Stem Cell Lineage | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |
9. Stem Cell Species | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |
10. Sex of the Donor | + | + | + | ||||||||||||||
11. Age of Donor | + | + | + | ||||||||||||||
12. Ethnicity of the Donor | + | ||||||||||||||||
13. Disease State of Donor | + | + | + | + | + | + | + | + | |||||||||
14. Developmental Stage | + | ||||||||||||||||
15. Cell Derivation Process | + | ||||||||||||||||
16. Differentiation Status | + | + | + | ||||||||||||||
17. Cell Morphology | + | ||||||||||||||||
18. Phenotype Quality | + | ||||||||||||||||
19. Tissue Type | + | + | + | + | + | + | + | ||||||||||
20. Tissue Histology | + | ||||||||||||||||
21. Cell Surface Markers | + | + | + | + | + | + | + | + | + | ||||||||
22. Transcription Factors Expression | + | + | + | + | + | + | |||||||||||
23. Epigenetic Modification | + | + | + | + | |||||||||||||
24. Gene Annotation | + | + | |||||||||||||||
25. miRNA-based Regulation/Interactions | + | + | |||||||||||||||
26. Protein Phosphorylation | + | ||||||||||||||||
27. Karyotype | + | + | + | ||||||||||||||
28. Mutation Status of a Donor | + | + | + | ||||||||||||||
29. Cell Culture Conditions | + | + | + | + | + | + | + | ||||||||||
4. Experimental Technology | 30. Immunoprecipitation Antibody | + | + | + | |||||||||||||
31. Gene Expression Data | + | + | + | + | + | ||||||||||||
32. Microarray Data | + | + | + | + | + | + | |||||||||||
33. miRNA Expression/Transcription | + | + | + | + | + | ||||||||||||
5. Data | 34. Sequencing Platform | + | + | + | + | + | + | + | + | + | + | + | + | ||||
35. Data analysis tools | + | + | + | + | + | + | + | + | + | + | + | + | + |